Cipher Pharmaceuticals Will Present at Piper Jaffray Healthcare Conference

Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX:CPH) has announced that it will be participating in the Piper Jaffray Healthcare Conference.
According to the press release:

Shawn Patrick O’Brien, President and Chief Executive Officer, and Norman Evans, Chief Financial Officer, will present at the 27th Annual Piper Jaffray Healthcare Conference in New York City onWednesday, December 2, 2015 at 3:30 PM ET. A live audio webcast will be available in the Investor Relations section of the Company’s website at www.cipherpharma.com.
[…] Cipher Pharmaceuticals is a rapidly growing specialty pharmaceutical dermatology company with a diversified portfolio of commercial-stage products with the goal of becoming the most customer-centric dermatology company in North America.

Click here to read the full press release.